Clinical Scorecard: Advancing beyond mere quantification: the role of single-cell long-read sequencing in elucidating transcriptomic complexity for precise therapeutic targets
At a Glance
Category
Detail
Condition
Key Mechanisms
Single-cell long-read sequencing (scLRS) overcomes limitations of short-read sequencing.
Target Population
Care Setting
Key Highlights
scLRS provides insights into immune infiltration and tumor heterogeneity.
Guideline-Based Recommendations
Diagnosis
Management
Utilize insights from scLRS for therapy development.
Monitoring & Follow-up
Employ scLRS to track tumor evolution.
Risks
Patient & Prescribing Data
Patients with various cancer types exhibiting genetic diversity and intratumoral heterogeneity.
scLRS can facilitate the development of precision therapies by identifying specific genomic alterations and splicing events.
Clinical Best Practices
Integrate multimodal analysis combining transcriptomics with genomic data.
